Michael Hoelscher
Clinical trials sponsored by Michael Hoelscher, explained in plain language.
-
New vaccine aims to tame chronic hepatitis b without daily pills
Disease control Recruiting nowThis study tests a therapeutic vaccine called TherVacB in 81 adults with chronic hepatitis B who are already on antiviral medication. The vaccine is given as a series of shots to boost the immune system and lower hepatitis B virus levels. The main goals are to check safety and se…
Phase: PHASE1, PHASE2 • Sponsor: Michael Hoelscher • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New TB drug cocktail aims to shorten treatment
Disease control Recruiting nowThis clinical trial is testing new combinations of tuberculosis (TB) drugs to see if they work better than the standard treatment. The study involves 390 adults with newly diagnosed, drug-sensitive TB. Researchers are comparing different drug regimens, including a new drug called…
Phase: PHASE2 • Sponsor: Michael Hoelscher • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC